{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:55:40Z","timestamp":1790942140943,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.autrev.2011.09.005","type":"journal-article","created":{"date-parts":[[2011,10,7]],"date-time":"2011-10-07T22:18:36Z","timestamp":1318025916000},"page":"149-153","source":"Crossref","is-referenced-by-count":155,"title":["Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly"],"prefix":"10.1016","volume":"11","author":[{"given":"F.","family":"Sardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Fassina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Venturini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Inguscio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Guerriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Rolfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ricevuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2011.09.005_bb0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0006-8993(03)02881-6","article-title":"Evidence linking neuronal cell death to autoimmunity in Alzheimer's disease","volume":"982","author":"D'Andrea","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.autrev.2011.09.005_bb0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.autrev.2006.07.002","article-title":"To smell the immune system: olfaction, autoimmunity and brain involvement","volume":"6","author":"Strous","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.09.005_bb0015","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1023\/A:1017964229295","article-title":"Dysregulation in neuroimmunopathology and perspectives of immunotherapy","volume":"131","author":"Evseev","year":"2001","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.autrev.2011.09.005_bb0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neulet.2005.01.082","article-title":"CD14 receptor polymorphism and Alzheimer's disease risk","volume":"380","author":"Combarros","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.autrev.2011.09.005_bb0025","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s00702-006-0524-4","article-title":"Alzheimer's disease, brain immune privilege and memory: a hypothesis","volume":"113","author":"Arshavsky","year":"2006","journal-title":"J Neural Transm"},{"key":"10.1016\/j.autrev.2011.09.005_bb0030","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1054\/mehy.2000.1148","article-title":"Alzheimer's disease: a review concerning immune response and microischemia","volume":"56","author":"Chorsky","year":"2001","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.autrev.2011.09.005_bb0035","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1532-5415.2007.01159.x","article-title":"Systemic markers of inflammation and cognitive decline in old age","volume":"55","author":"Schram","year":"2007","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.autrev.2011.09.005_bb0040","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jaut.2010.06.008","article-title":"The odd couple: a fresh look at autoimmunity and immunodeficiency","volume":"35","author":"Mackay","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2011.09.005_bb0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-4933-3-2","article-title":"Age and immunity","volume":"3","author":"Vasto","year":"2006","journal-title":"Immun Ageing"},{"key":"10.1016\/j.autrev.2011.09.005_bb0050","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1471-4914(02)02422-X","article-title":"The possible role of complement activation in Alzheimer disease","volume":"8","author":"McGeer","year":"2002","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.autrev.2011.09.005_bb0055","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaut.2004.05.005","article-title":"Antibody to serum amyloid A","volume":"23","author":"Rosenau","year":"2004","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2011.09.005_bb0060","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.exger.2003.10.028","article-title":"Paradoxical age-related cell cycle quickening of human CD4(+) lymphocytes: a role for cyclin D1 and calpain","volume":"39","author":"Witkowski","year":"2004","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.autrev.2011.09.005_bb0065","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.autrev.2008.04.007","article-title":"Immunological tolerance and the autoimmune response","volume":"7","author":"Davies","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.09.005_bb0355","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflamm-aging. An evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2011.09.005_bb0075","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.autrev.2004.03.004","article-title":"Inflamm-aging: autoimmunity, and the immune-risk phenotype","volume":"3","author":"Boren","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.09.005_bb0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-4933-3-12","article-title":"Is inflammaging an auto[innate]immunity subclinical syndrome?","volume":"3","author":"Giunta","year":"2006","journal-title":"Immun Ageing"},{"key":"10.1016\/j.autrev.2011.09.005_bb0085","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.autrev.2007.11.021","article-title":"The mosaic of autoimmunity","volume":"7","author":"Gershwin","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.09.005_bb0090","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.autrev.2007.11.007","article-title":"Stress as a trigger of autoimmune disease","volume":"7","author":"Stojanovich","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.09.005_bb0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.autrev.2007.03.002","article-title":"Regulatory pathways in inflammation","volume":"7","author":"Mantovani","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.09.005_bb0100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/187152710791012008","article-title":"Inflammation, immunity, and Alzheimer's disease","volume":"9","author":"Town","year":"2010","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.autrev.2011.09.005_bb0105","first-page":"83","article-title":"Hyperferritinemia in autoimmunity","volume":"10","author":"Zandman-Goddard","year":"2008","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.autrev.2011.09.005_bb0110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1742-1241.2003.tb11394.x","article-title":"Inflammation and Alzheimer's disease","volume":"57","author":"Gupta","year":"2003","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.autrev.2011.09.005_bb0115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1749-6632.2003.tb03138.x","article-title":"Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection","volume":"992","author":"van Beek","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2011.09.005_bb0120","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.autrev.2010.12.006","article-title":"Inflammation as \u201ccommon soil\u201d of the multifactorial diseases","volume":"10","author":"Scrivo","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.09.005_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt24","article-title":"Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy","volume":"2","author":"Zotova","year":"2010","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.autrev.2011.09.005_bb0130","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.autrev.2008.03.004","article-title":"Catalytic antibodies to amyloid beta peptide in defense against Alzheimer disease","volume":"7","author":"Taguchi","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.09.005_bb0135","first-page":"22","article-title":"Innate immunity in Alzheimer's disease: a model for local inflammatory reactions","volume":"1","author":"McGeer","year":"2001","journal-title":"Mol Interv"},{"key":"10.1016\/j.autrev.2011.09.005_bb0140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1474-9728.2004.00101.x","article-title":"How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes","volume":"3","author":"Blasko","year":"2004","journal-title":"Aging Cell"},{"key":"10.1016\/j.autrev.2011.09.005_bb0145","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn.2432","article-title":"Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia","volume":"12","author":"Grathwohl","year":"2009","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.autrev.2011.09.005_bb0150","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/alzrt6","article-title":"Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease","volume":"1","author":"Weller","year":"2009","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.autrev.2011.09.005_bb0155","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2003.10.013","article-title":"Neurodegenerative disease and the neuroimmune axis (Alzheimer's and Parkinson's disease, and viral infections)","volume":"147","author":"Ringheim","year":"2004","journal-title":"J Neuroimmunol"},{"issue":"Suppl","key":"10.1016\/j.autrev.2011.09.005_bb0160","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2005.09.024","article-title":"Infections and autoimmune diseases","volume":"25","author":"Bach","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2011.09.005_bb0165","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0197-4580(01)00287-1","article-title":"Interleukin-1, neuroinflammation, and Alzheimer's disease","volume":"22","author":"Mrak","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.autrev.2011.09.005_bb0170","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-4933-6-12","article-title":"Pathophysiology of age-related diseases","volume":"6","author":"Campisi","year":"2009","journal-title":"Immun Ageing"},{"key":"10.1016\/j.autrev.2011.09.005_bb0175","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0197-4580(03)00011-3","article-title":"Interleukin-1B polymorphism is associated with age at onset of Alzheimer's disease","volume":"24","author":"Sciacca","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.autrev.2011.09.005_bb0180","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neurobiolaging.2003.10.009","article-title":"Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease","volume":"25","author":"Arosio","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.autrev.2011.09.005_bb0185","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/sj.gene.6363964","article-title":"Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease","volume":"4","author":"Lio","year":"2003","journal-title":"Genes Immun"},{"key":"10.1016\/j.autrev.2011.09.005_bb0190","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-4933-2-8","article-title":"Innate immunity and inflammation in ageing: a key for understanding age-related diseases","volume":"2","author":"Licastro","year":"2005","journal-title":"Immun Ageing"},{"key":"10.1016\/j.autrev.2011.09.005_bb0360","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.1016\/S0021-9258(19)52510-8","article-title":"Human E apoprotein heterogeneity. Cysteine\u2013arginine interchanges in the amino acid sequence of the apo-E isoforms","volume":"256","author":"Weisgraber","year":"1981","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2011.09.005_bb0200","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.neurobiolaging.2006.07.007","article-title":"Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation","volume":"28","author":"Licastro","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.autrev.2011.09.005_bb0205","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.20390","article-title":"Vascular endothelial growth factor gene variability is associated with increased risk for AD","volume":"57","author":"Del Bo","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2011.09.005_bb0210","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2011.09.005_bb0215","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1600-0404.1994.tb01660.x","article-title":"Altered blood\u2013brain-barrier function in Alzheimer's disease?","volume":"89","author":"Mattila","year":"1994","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.autrev.2011.09.005_bb0220","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.mod.2007.08.002","article-title":"Embryonic stem cells and retinal repair","volume":"124","author":"Vugler","year":"2007","journal-title":"Mech Dev"},{"key":"10.1016\/j.autrev.2011.09.005_bb0225","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.mehy.2004.08.024","article-title":"Add Alzheimer's disease to the list of autoimmune diseases","volume":"64","author":"D'Andrea","year":"2005","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.autrev.2011.09.005_bb0230","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0925-4439(00)00042-9","article-title":"The role of complement in Alzheimer's disease pathology","volume":"1502","author":"Emmerling","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"re3","key":"10.1016\/j.autrev.2011.09.005_bb0365","first-page":"1","article-title":"Innate immunity, local inflammation, and degenerative disease","volume":"2002","author":"McGeer","year":"2002","journal-title":"Sci Aging Knowledge Environ"},{"key":"10.1016\/j.autrev.2011.09.005_bb0240","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0197-4580(88)80141-6","article-title":"Autoimmunity and age-associated cognitive decline","volume":"9","author":"Lal","year":"1988","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.autrev.2011.09.005_bb0245","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1513\/pats.200603-061MS","article-title":"State of the art. Four easy pieces: interconnections between tissue injury, intermediary metabolism, autoimmunity, and chronic degeneration","volume":"3","author":"Steinman","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.autrev.2011.09.005_bb0250","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1586\/14737175.7.11.1535","article-title":"Immunotherapy as treatment for Alzheimer's disease","volume":"7","author":"Hawkes","year":"2007","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.autrev.2011.09.005_bb0255","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/08916938909019958","article-title":"Increase of immunoglobulin G3 subclass is related to brain autoantibody in Alzheimer's disease but not in Down's syndrome","volume":"3","author":"Singh","year":"1989","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2011.09.005_bb0260","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0304-3940(92)90766-Z","article-title":"Immunoblot detection of antibodies to myelin basic protein in Alzheimer's disease patients","volume":"147","author":"Singh","year":"1992","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.autrev.2011.09.005_bb0265","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF02815211","article-title":"Immune-activation model in Alzheimer disease","volume":"28","author":"Singh","year":"1996","journal-title":"Mol Chem Neuropathol"},{"key":"10.1016\/j.autrev.2011.09.005_bb0270","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-3-642-00549-7_8","article-title":"Toll-like receptors in Alzheimer's disease","volume":"336","author":"Landreth","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.autrev.2011.09.005_bb0275","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-2-9","article-title":"Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease","volume":"2","author":"Patel","year":"2005","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.autrev.2011.09.005_bb0280","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/nn1997","article-title":"Microglia: active sensor and versatile effector cells in the normal and pathologic brain","volume":"10","author":"Hanisch","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.autrev.2011.09.005_bb0285","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-4886(90)90054-V","article-title":"Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain","volume":"110","author":"Styren","year":"1990","journal-title":"Exp Neurol"},{"key":"10.1016\/j.autrev.2011.09.005_bb0290","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1096\/fj.03-0364fje","article-title":"The LPS receptor (CD14) links innate immunity with Alzheimer's disease","volume":"18","author":"Fassbender","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.autrev.2011.09.005_bb0295","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/jnr.20767","article-title":"Toll-like receptors in central nervous system glial inflammation and homeostasis","volume":"83","author":"Kielian","year":"2006","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.autrev.2011.09.005_bb0300","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1159\/000110455","article-title":"Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease","volume":"20","author":"Walter","year":"2007","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.autrev.2011.09.005_bb0305","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1471-4159.2007.05001.x","article-title":"Toll-like receptors 2 and 4 mediate Abeta(1\u201342) activation of the innate immune response in a human monocytic cell line","volume":"104","author":"Udan","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.autrev.2011.09.005_bb0310","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jneuroim.2007.03.023","article-title":"Differential neuroimmune markers to the onset of Alzheimer's disease neurodegeneration and dementia: autoantibodies to Abeta((25\u201335)) oligomers, S100b and neurotransmitters","volume":"186","author":"Gruden","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2011.09.005_bb0315","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.autrev.2010.07.008","article-title":"Autoantibodies in patients with Alzheimer's disease: pathogenetic role and potential use as biomarkers of disease progression","volume":"9","author":"Colasanti","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.09.005_bb0320","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.autrev.2005.06.007","article-title":"Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies","volume":"5","author":"Geylis","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.09.005_bb0325","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.autrev.2008.03.005","article-title":"Natural antibodies in health and disease: an overview of the first international workshop on natural antibodies in health and disease","volume":"7","author":"Lutz","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.09.005_bb0330","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/08916930701421020","article-title":"Redox-reactive autoantibodies in Alzheimer's patients' cerebrospinal fluids: preliminary studies","volume":"40","author":"McIntyre","year":"2007","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2011.09.005_bb0335","doi-asserted-by":"crossref","first-page":"17458","DOI":"10.1074\/jbc.M414176200","article-title":"Autoantibodies to redox-modified oligomeric Abeta are attenuated in the plasma of Alzheimer's disease patients","volume":"280","author":"Moir","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2011.09.005_bb0340","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.autrev.2008.03.007","article-title":"Natural human antibodies to amyloid beta peptide","volume":"7","author":"Szabo","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.09.005_bb0345","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.autrev.2008.04.010","article-title":"Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders","volume":"7","author":"Neff","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.09.005_bb0350","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2165\/11533070-000000000-00000","article-title":"Intravenous immunoglobulins as a treatment for Alzheimer's disease: rationale and current evidence","volume":"70","author":"Dodel","year":"2010","journal-title":"Drugs"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211002047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211002047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T12:01:10Z","timestamp":1713009670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997211002047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1568997211002047"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2011.09.005","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}